Effectiveness of preanesthetic administration of gabapentin on sedative action during intravenous sedation with propofol

Rumiko Hosokawa, Shinichi Ito, Jun Hirokawa, Yu Oshima, Takeshi Yokoyama

研究成果: ジャーナルへの寄稿記事

抄録

Purpose: There are no sufficient evidences for the sedative effect of gabapentin during anesthesia, especially intravenous sedation (IVS). The purpose of this study was to evaluate the sedative effect of gabapentin as preanesthetic medication during the IVS with propofol. Methods: 10 volunteer subjects joined this study. They underwent propofol IVS three times on separate days. On the first day, the IVS without gabapentin was performed as a control. On the second and the third day, gabapentin 200 mg and 400 mg were administered before the IVS, respectively. The target blood concentration (CT) of propofol was gradually increased, and the bispectral index (BIS) value and Ramsay sedation score (RSS) were evaluated at each propofol CT. Postanesthetic complications and influences on vital signs were also evaluated. Results: Compared to the control group, the propofol CTs in the gabapentin 400 mg group significantly reduced at the BIS values of 60 and 70 (p = 0.031 and p = 0.043, respectively), and at RSS 3, 4, 5 and 6 (p = 0.040, p = 0.004, p = 0.001 and p = 0.004, respectively). There was no significant difference in propofol CTs between the control group and the gabapentin 200 mg group. There were no abnormality and no deterioration in circulation and respiration in all groups. There were no significant increases in complications with the administration of gabapentin. Conclusion: The oral administration of 400 mg dose of gabapentin reduced the propofol CTs for achieving an adequate sedation level on IVS.

元の言語英語
ページ(範囲)813-821
ページ数9
ジャーナルJournal of Anesthesia
32
発行部数6
DOI
出版物ステータス出版済み - 12 1 2018

Fingerprint

Propofol
Hypnotics and Sedatives
Preanesthetic Medication
Intravenous Anesthesia
Control Groups
gabapentin
Vital Signs
Oral Administration
Volunteers
Respiration

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

これを引用

Effectiveness of preanesthetic administration of gabapentin on sedative action during intravenous sedation with propofol. / Hosokawa, Rumiko; Ito, Shinichi; Hirokawa, Jun; Oshima, Yu; Yokoyama, Takeshi.

:: Journal of Anesthesia, 巻 32, 番号 6, 01.12.2018, p. 813-821.

研究成果: ジャーナルへの寄稿記事

@article{2f4b370ca1c048318d0a74dc8e34a4d1,
title = "Effectiveness of preanesthetic administration of gabapentin on sedative action during intravenous sedation with propofol",
abstract = "Purpose: There are no sufficient evidences for the sedative effect of gabapentin during anesthesia, especially intravenous sedation (IVS). The purpose of this study was to evaluate the sedative effect of gabapentin as preanesthetic medication during the IVS with propofol. Methods: 10 volunteer subjects joined this study. They underwent propofol IVS three times on separate days. On the first day, the IVS without gabapentin was performed as a control. On the second and the third day, gabapentin 200 mg and 400 mg were administered before the IVS, respectively. The target blood concentration (CT) of propofol was gradually increased, and the bispectral index (BIS) value and Ramsay sedation score (RSS) were evaluated at each propofol CT. Postanesthetic complications and influences on vital signs were also evaluated. Results: Compared to the control group, the propofol CTs in the gabapentin 400 mg group significantly reduced at the BIS values of 60 and 70 (p = 0.031 and p = 0.043, respectively), and at RSS 3, 4, 5 and 6 (p = 0.040, p = 0.004, p = 0.001 and p = 0.004, respectively). There was no significant difference in propofol CTs between the control group and the gabapentin 200 mg group. There were no abnormality and no deterioration in circulation and respiration in all groups. There were no significant increases in complications with the administration of gabapentin. Conclusion: The oral administration of 400 mg dose of gabapentin reduced the propofol CTs for achieving an adequate sedation level on IVS.",
author = "Rumiko Hosokawa and Shinichi Ito and Jun Hirokawa and Yu Oshima and Takeshi Yokoyama",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s00540-018-2559-8",
language = "English",
volume = "32",
pages = "813--821",
journal = "Journal of Anesthesia",
issn = "0913-8668",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Effectiveness of preanesthetic administration of gabapentin on sedative action during intravenous sedation with propofol

AU - Hosokawa, Rumiko

AU - Ito, Shinichi

AU - Hirokawa, Jun

AU - Oshima, Yu

AU - Yokoyama, Takeshi

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Purpose: There are no sufficient evidences for the sedative effect of gabapentin during anesthesia, especially intravenous sedation (IVS). The purpose of this study was to evaluate the sedative effect of gabapentin as preanesthetic medication during the IVS with propofol. Methods: 10 volunteer subjects joined this study. They underwent propofol IVS three times on separate days. On the first day, the IVS without gabapentin was performed as a control. On the second and the third day, gabapentin 200 mg and 400 mg were administered before the IVS, respectively. The target blood concentration (CT) of propofol was gradually increased, and the bispectral index (BIS) value and Ramsay sedation score (RSS) were evaluated at each propofol CT. Postanesthetic complications and influences on vital signs were also evaluated. Results: Compared to the control group, the propofol CTs in the gabapentin 400 mg group significantly reduced at the BIS values of 60 and 70 (p = 0.031 and p = 0.043, respectively), and at RSS 3, 4, 5 and 6 (p = 0.040, p = 0.004, p = 0.001 and p = 0.004, respectively). There was no significant difference in propofol CTs between the control group and the gabapentin 200 mg group. There were no abnormality and no deterioration in circulation and respiration in all groups. There were no significant increases in complications with the administration of gabapentin. Conclusion: The oral administration of 400 mg dose of gabapentin reduced the propofol CTs for achieving an adequate sedation level on IVS.

AB - Purpose: There are no sufficient evidences for the sedative effect of gabapentin during anesthesia, especially intravenous sedation (IVS). The purpose of this study was to evaluate the sedative effect of gabapentin as preanesthetic medication during the IVS with propofol. Methods: 10 volunteer subjects joined this study. They underwent propofol IVS three times on separate days. On the first day, the IVS without gabapentin was performed as a control. On the second and the third day, gabapentin 200 mg and 400 mg were administered before the IVS, respectively. The target blood concentration (CT) of propofol was gradually increased, and the bispectral index (BIS) value and Ramsay sedation score (RSS) were evaluated at each propofol CT. Postanesthetic complications and influences on vital signs were also evaluated. Results: Compared to the control group, the propofol CTs in the gabapentin 400 mg group significantly reduced at the BIS values of 60 and 70 (p = 0.031 and p = 0.043, respectively), and at RSS 3, 4, 5 and 6 (p = 0.040, p = 0.004, p = 0.001 and p = 0.004, respectively). There was no significant difference in propofol CTs between the control group and the gabapentin 200 mg group. There were no abnormality and no deterioration in circulation and respiration in all groups. There were no significant increases in complications with the administration of gabapentin. Conclusion: The oral administration of 400 mg dose of gabapentin reduced the propofol CTs for achieving an adequate sedation level on IVS.

UR - http://www.scopus.com/inward/record.url?scp=85053664278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053664278&partnerID=8YFLogxK

U2 - 10.1007/s00540-018-2559-8

DO - 10.1007/s00540-018-2559-8

M3 - Article

C2 - 30238330

AN - SCOPUS:85053664278

VL - 32

SP - 813

EP - 821

JO - Journal of Anesthesia

JF - Journal of Anesthesia

SN - 0913-8668

IS - 6

ER -